FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称INLEXISERTIB
异名/同义词1,4-OXAZEPIN-5(2H)-ONE, 4-(3-((2-((2-ETHYL-4-(4-METHYL-1-PIPERAZINYL)PHENYL)AMINO)-5-(TRIFLUOROMETHYL)-4-PYRIMIDINYL)AMINO)PROPYL)TETRAHYDRO-
4-(3-((2-((2-ETHYL-4-(4-METHYL-1-PIPERAZINYL)PHENYL)AMINO)-5-(TRIFLUOROMETHYL)-4-PYRIMIDINYL)AMINO)PROPYL)TETRAHYDRO-1,4-OXAZEPIN-5(2H)-ONE
DCC3116 FREE BASE
DCC-3116 FREE BASE
INLEXISERTIB
INLEXISERTIB [INN]
CAS登记号2543673-19-2
物质唯一标识(Unique Ingredient Identifier)JM2ZTM8S7S
分子式C26H36F3N7O2
国际化合物标识(International Chemical Identifier,InChI)CNBTYICEJGEABG-UHFFFAOYSA-N
SMILESC(c1cnc(Nc2c(CC)cc(cc2)N3CCN(C)CC3)nc1NCCCN4C(=O)CCOCC4)(F)(F)F
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2025 Drugfuture->FDA Global Substance Registration System